HALO
Price
$54.25
Change
+$0.70 (+1.31%)
Updated
Jun 6 closing price
Capitalization
6.68B
65 days until earnings call
VIR
Price
$5.45
Change
+$0.30 (+5.83%)
Updated
Jun 6 closing price
Capitalization
753.4M
54 days until earnings call
Interact to see
Advertisement

HALO vs VIR

Header iconHALO vs VIR Comparison
Open Charts HALO vs VIRBanner chart's image
Halozyme Therapeutics
Price$54.25
Change+$0.70 (+1.31%)
Volume$1.31M
Capitalization6.68B
Vir Biotechnology
Price$5.45
Change+$0.30 (+5.83%)
Volume$1.34M
Capitalization753.4M
HALO vs VIR Comparison Chart
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HALO vs. VIR commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Buy and VIR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (HALO: $54.25 vs. VIR: $5.45)
Brand notoriety: HALO and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 54% vs. VIR: 102%
Market capitalization -- HALO: $6.68B vs. VIR: $753.4M
HALO [@Biotechnology] is valued at $6.68B. VIR’s [@Biotechnology] market capitalization is $753.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, HALO is a better buy in the long-term than VIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 7 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • HALO’s TA Score: 7 bullish, 3 bearish.
  • VIR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HALO is a better buy in the short-term than VIR.

Price Growth

HALO (@Biotechnology) experienced а -3.25% price change this week, while VIR (@Biotechnology) price change was +10.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

HALO is expected to report earnings on Aug 12, 2025.

VIR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($6.69B) has a higher market cap than VIR($753M). HALO YTD gains are higher at: 13.470 vs. VIR (-25.749). HALO has higher annual earnings (EBITDA): 705M vs. VIR (-598.69M). VIR has more cash in the bank: 802M vs. HALO (748M). VIR has less debt than HALO: VIR (96.1M) vs HALO (1.51B). HALO has higher revenues than VIR: HALO (1.08B) vs VIR (14.3M).
HALOVIRHALO / VIR
Capitalization6.69B753M888%
EBITDA705M-598.69M-118%
Gain YTD13.470-25.749-52%
P/E Ratio14.43N/A-
Revenue1.08B14.3M7,580%
Total Cash748M802M93%
Total Debt1.51B96.1M1,568%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALOVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 25 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGOCX12.27N/A
N/A
PGIM Jennison Global Equity Income C
RYNCX102.82N/A
N/A
Rydex Nova C
LCEYX18.31N/A
N/A
Invesco Diversified Dividend Y
MTCAX61.89N/A
N/A
MFS Technology A
LKSMX11.52N/A
N/A
LKCM Small-Mid Cap Equity Institutional

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+5.83%
SANA - VIR
63%
Loosely correlated
+11.37%
AXON - VIR
47%
Loosely correlated
+1.52%
CPRX - VIR
45%
Loosely correlated
+2.01%
GOSS - VIR
41%
Loosely correlated
+5.56%
IMNM - VIR
41%
Loosely correlated
+0.11%
More